These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 444255)

  • 1. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor-coupled modulation of the K+-depolarized overflow of 3H-acetylcholine from rat striatal slices: alteration after chronic haloperidol and alpha-methyl-p-tyrosine pretreatment.
    Miller JC; Friedhoff AJ
    Life Sci; 1979 Oct; 25(14):1249-55. PubMed ID: 513956
    [No Abstract]   [Full Text] [Related]  

  • 4. An analysis of the effects of apomorphine and haloperidol on the release of [3H]-dopamine and [3H]-noradrenaline from rabbit brain slices.
    Kelly MJ
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):18-29. PubMed ID: 7271378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the endogenous acetylcholine release from rat striatal slices.
    Alberch J; Marsal J; Solsona C
    Brain Res; 1985 Nov; 346(2):353-6. PubMed ID: 2996707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitro.
    Brase DA
    J Pharm Pharmacol; 1980 Jun; 32(6):432-3. PubMed ID: 6106680
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of apomorphine and pergolide on the potassium-evoked overflow of GABA in rat striatum studied by microdialysis.
    Tossman U; Ungerstedt U
    Eur J Pharmacol; 1986 Apr; 123(2):295-8. PubMed ID: 3709666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection.
    Bonanno G; Fedele E; Versace P; Raiteri M
    Brain Res; 1989 Feb; 480(1-2):242-8. PubMed ID: 2713653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interneurones are probably not involved in the presynaptic dopaminergic control of dopamine release in rabbit caudate nucleus.
    Jackisch R; Zumstein A; Hertting G; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):129-33. PubMed ID: 7453832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum.
    Kashihara K; Fukuda K; Sato M; Otsuki S
    Neurosci Res; 1987 Jun; 4(5):428-32. PubMed ID: 3670749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.